Vaxil Bio Ltd.
VXL.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 320.90K | 254.40K | 280.40K | 311.40K | 396.00K |
| Total Receivables | 112.00K | 203.80K | 195.50K | 189.70K | 211.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | 8.30K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 432.90K | 458.30K | 475.90K | 509.40K | 607.00K |
|
|
|||||
| Total Current Assets | 432.90K | 458.30K | 475.90K | 509.40K | 607.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 484.60K | 511.10K | 475.90K | 509.40K | 607.00K |
|
|
|||||
| Total Accounts Payable | 2.20K | 700.00 | 24.40K | 8.30K | 60.70K |
| Total Accrued Expenses | 3.60K | 3.70K | 3.50K | 3.50K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.70K | 4.40K | 27.80K | 11.80K | 60.70K |
|
|
|||||
| Total Current Liabilities | 5.70K | 4.40K | 27.80K | 11.80K | 60.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.70K | 4.40K | 27.80K | 11.80K | 60.70K |
|
|
|||||
| Common Stock & APIC | 11.54M | 11.79M | 11.18M | 11.17M | 11.90M |
| Retained Earnings | -14.06M | -14.34M | -13.64M | -13.58M | -14.44M |
| Treasury Stock & Other | 3.00M | 3.06M | 2.90M | 2.90M | 3.09M |
| Total Common Equity | 478.90K | 506.70K | 448.00K | 497.60K | 546.30K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 478.90K | 506.70K | 448.00K | 497.60K | 546.30K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 478.90K | 506.70K | 448.00K | 497.60K | 546.30K |
|
|
|||||